SABER-Bupivacaine for Post-Operative Pain and Opioid Consumption for Subacromial Decompression
How to Cite
OrthoEvidence. SABER-Bupivacaine for Post-Operative Pain and Opioid Consumption for Subacromial Decompression. ACE Report. 2022;261(1):4. Available from: https://myorthoevidence.com/AceReport/Report/14743
SABER-Bupivacaine Reduces Postoperative Pain and Opioid Consumption After Arthroscopic Subacromial Decompression: A Randomized, Placebo-Controlled TrialJ Am Acad Orthop Surg Glob Res Rev . 2022 May 1;6(5).
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
One hundred and seven patients undergoing an arthroscopic subacromial decompression (ASD) surgery were randomized (in a 2:1:1 ratio) to receive either sucrose acetate isobutyrate extended-release (SABER) bupivacaine (n=53), SABER-placebo (n=25), or bupivacaine HCl (n=29) to minimize post-operative pain and opioid consumption. The primary outcomes of this trial were to assess pain scores and analge...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE